nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxacurium chloride—BCHE—Irinotecan—lung cancer	0.17	0.551	CbGbCtD
Doxacurium chloride—BCHE—Cisplatin—lung cancer	0.139	0.449	CbGbCtD
Doxacurium chloride—CHRND—pericardium—lung cancer	0.0783	0.446	CbGeAlD
Doxacurium chloride—BCHE—diaphragm—lung cancer	0.0359	0.205	CbGeAlD
Doxacurium chloride—CHRNA2—mammary gland—lung cancer	0.0155	0.0884	CbGeAlD
Doxacurium chloride—CHRND—respiratory system—lung cancer	0.0149	0.085	CbGeAlD
Doxacurium chloride—CHRND—lung—lung cancer	0.00792	0.0452	CbGeAlD
Doxacurium chloride—BCHE—respiratory system—lung cancer	0.0041	0.0234	CbGeAlD
Doxacurium chloride—CHRNB1—lymph node—lung cancer	0.00349	0.0199	CbGeAlD
Doxacurium chloride—BCHE—bronchus—lung cancer	0.00337	0.0192	CbGeAlD
Doxacurium chloride—BCHE—trachea—lung cancer	0.00303	0.0173	CbGeAlD
Doxacurium chloride—BCHE—cardiac atrium—lung cancer	0.00284	0.0162	CbGeAlD
Doxacurium chloride—BCHE—bone marrow—lung cancer	0.0024	0.0137	CbGeAlD
Doxacurium chloride—BCHE—lung—lung cancer	0.00218	0.0124	CbGeAlD
Doxacurium chloride—BCHE—lymph node—lung cancer	0.00149	0.00848	CbGeAlD
Doxacurium chloride—CHRNA2—Neuronal System—RAF1—lung cancer	0.000208	0.000404	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—ATP5H—lung cancer	0.000206	0.000399	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—OXTR—lung cancer	0.000204	0.000397	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—GRP—lung cancer	0.000204	0.000397	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—HIF1A—lung cancer	0.000201	0.000391	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	0.000199	0.000386	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—ANXA1—lung cancer	0.000198	0.000383	CbGpPWpGaD
Doxacurium chloride—BCHE—Phospholipid metabolism—PIK3CB—lung cancer	0.000197	0.000382	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—GNG11—lung cancer	0.000191	0.000371	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	0.000189	0.000367	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—GRP—lung cancer	0.000189	0.000367	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—APP—lung cancer	0.000187	0.000363	CbGpPWpGaD
Doxacurium chloride—CHRND—Transmission across Chemical Synapses—HRAS—lung cancer	0.000185	0.00036	CbGpPWpGaD
Doxacurium chloride—CHRM2—Regulation of Actin Cytoskeleton—APC—lung cancer	0.000184	0.000357	CbGpPWpGaD
Doxacurium chloride—CHRM2—Regulation of Actin Cytoskeleton—PIK3CG—lung cancer	0.000184	0.000357	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—PLBD1—lung cancer	0.000183	0.000356	CbGpPWpGaD
Doxacurium chloride—CHRM2—Regulation of Actin Cytoskeleton—EGF—lung cancer	0.000182	0.000353	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	0.00018	0.00035	CbGpPWpGaD
Doxacurium chloride—BCHE—Transmission across Chemical Synapses—BRAF—lung cancer	0.00018	0.000349	CbGpPWpGaD
Doxacurium chloride—CHRM2—Regulation of Actin Cytoskeleton—BRAF—lung cancer	0.000173	0.000336	CbGpPWpGaD
Doxacurium chloride—BCHE—Phospholipid metabolism—PTEN—lung cancer	0.00017	0.00033	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—HSD17B10—lung cancer	0.000168	0.000326	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—GIPR—lung cancer	0.000165	0.00032	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—IL6R—lung cancer	0.000165	0.00032	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—ATF3—lung cancer	0.000165	0.000319	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—CREBBP—lung cancer	0.000165	0.000319	CbGpPWpGaD
Doxacurium chloride—CHRM2—Regulation of Actin Cytoskeleton—MAP2K1—lung cancer	0.000163	0.000316	CbGpPWpGaD
Doxacurium chloride—CHRM2—Regulation of Actin Cytoskeleton—PIK3CD—lung cancer	0.000162	0.000314	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—PTHLH—lung cancer	0.00016	0.000311	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Transmission across Chemical Synapses—HRAS—lung cancer	0.000157	0.000306	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—CKB—lung cancer	0.000156	0.000303	CbGpPWpGaD
Doxacurium chloride—BCHE—Transmission across Chemical Synapses—MDM2—lung cancer	0.00015	0.000292	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—ANXA1—lung cancer	0.00015	0.000292	CbGpPWpGaD
Doxacurium chloride—BCHE—Transmission across Chemical Synapses—RAF1—lung cancer	0.00015	0.000291	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—GIPR—lung cancer	0.00015	0.000291	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Transmission across Chemical Synapses—HRAS—lung cancer	0.00015	0.00029	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—LMNA—lung cancer	0.000148	0.000287	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—GSTM2—lung cancer	0.000147	0.000285	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—CNDP2—lung cancer	0.000147	0.000285	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—AVP—lung cancer	0.000146	0.000283	CbGpPWpGaD
Doxacurium chloride—CHRM2—Regulation of Actin Cytoskeleton—RAF1—lung cancer	0.000144	0.00028	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—MTMR3—lung cancer	0.000143	0.000277	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—APP—lung cancer	0.000143	0.000277	CbGpPWpGaD
Doxacurium chloride—CHRND—Neuronal System—HRAS—lung cancer	0.000142	0.000275	CbGpPWpGaD
Doxacurium chloride—CHRM2—Regulation of Actin Cytoskeleton—PIK3CB—lung cancer	0.000141	0.000274	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—GRM8—lung cancer	0.00014	0.000272	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—PGAM1—lung cancer	0.000139	0.00027	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—BRAF—lung cancer	0.000138	0.000267	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—CYP2A7—lung cancer	0.000133	0.000257	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—CXCL8—lung cancer	0.000131	0.000254	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—SDC4—lung cancer	0.00013	0.000252	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—GRM8—lung cancer	0.000127	0.000247	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—CASP3—lung cancer	0.000125	0.000243	CbGpPWpGaD
Doxacurium chloride—CHRM2—G alpha (i) signalling events—POMC—lung cancer	0.000122	0.000236	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—JUN—lung cancer	0.000121	0.000236	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Neuronal System—HRAS—lung cancer	0.000121	0.000234	CbGpPWpGaD
Doxacurium chloride—BCHE—Phospholipid metabolism—PIK3CA—lung cancer	0.00012	0.000233	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—RRM1—lung cancer	0.000118	0.000229	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—GSTA3—lung cancer	0.000118	0.000229	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—AXL—lung cancer	0.000117	0.000227	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—OXTR—lung cancer	0.000116	0.000224	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—GRP—lung cancer	0.000116	0.000224	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—MDM2—lung cancer	0.000115	0.000224	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—RAF1—lung cancer	0.000115	0.000223	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Neuronal System—HRAS—lung cancer	0.000115	0.000223	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—EP300—lung cancer	0.000112	0.000218	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—B4GALT5—lung cancer	0.000111	0.000216	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—AVP—lung cancer	0.000111	0.000215	CbGpPWpGaD
Doxacurium chloride—CHRM2—Regulation of Actin Cytoskeleton—NRAS—lung cancer	0.000109	0.000211	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—GNG11—lung cancer	0.000108	0.00021	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—GSTA4—lung cancer	0.000108	0.00021	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—VEGFA—lung cancer	0.000106	0.000206	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	0.000106	0.000205	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—GSTA2—lung cancer	0.000105	0.000204	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—OXTR—lung cancer	0.000105	0.000204	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—GRP—lung cancer	0.000105	0.000204	CbGpPWpGaD
Doxacurium chloride—CHRM2—Regulation of Actin Cytoskeleton—MAPK3—lung cancer	0.000104	0.000202	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—GSTA1—lung cancer	0.000102	0.000197	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—ABCC3—lung cancer	0.000101	0.000195	CbGpPWpGaD
Doxacurium chloride—CHRM2—Regulation of Actin Cytoskeleton—EGFR—lung cancer	9.91e-05	0.000192	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—GNG11—lung cancer	9.82e-05	0.000191	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—AKR1C1—lung cancer	9.73e-05	0.000189	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—ADCY1—lung cancer	9.73e-05	0.000189	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—lung cancer	9.68e-05	0.000188	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—UGT1A1—lung cancer	9.45e-05	0.000183	CbGpPWpGaD
Doxacurium chloride—CHRM2—G alpha (i) signalling events—CXCL8—lung cancer	9.42e-05	0.000183	CbGpPWpGaD
Doxacurium chloride—CHRM2—Regulation of Actin Cytoskeleton—KRAS—lung cancer	9.36e-05	0.000182	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—GNG11—lung cancer	9.11e-05	0.000177	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—COL4A2—lung cancer	9.08e-05	0.000176	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—APOA1—lung cancer	9.07e-05	0.000176	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—PTHLH—lung cancer	9.04e-05	0.000175	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—GIPR—lung cancer	8.85e-05	0.000172	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—ADCY1—lung cancer	8.83e-05	0.000171	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—ALDOA—lung cancer	8.68e-05	0.000168	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—PPP2R1B—lung cancer	8.61e-05	0.000167	CbGpPWpGaD
Doxacurium chloride—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—lung cancer	8.6e-05	0.000167	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—ANXA1—lung cancer	8.5e-05	0.000165	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—NCOA3—lung cancer	8.42e-05	0.000163	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	8.28e-05	0.000161	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—SDC4—lung cancer	8.26e-05	0.00016	CbGpPWpGaD
Doxacurium chloride—BCHE—Transmission across Chemical Synapses—HRAS—lung cancer	8.26e-05	0.00016	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—PTHLH—lung cancer	8.21e-05	0.000159	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—ADCY1—lung cancer	8.19e-05	0.000159	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—ABCG2—lung cancer	8.19e-05	0.000159	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—MMP1—lung cancer	8.19e-05	0.000159	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—DUSP3—lung cancer	8.1e-05	0.000157	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—APP—lung cancer	8.06e-05	0.000156	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—ENO2—lung cancer	8.04e-05	0.000156	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—HPGDS—lung cancer	8.04e-05	0.000156	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—PPP2R1B—lung cancer	7.98e-05	0.000155	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—RHEB—lung cancer	7.94e-05	0.000154	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—POMC—lung cancer	7.88e-05	0.000153	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—GSTT1—lung cancer	7.79e-05	0.000151	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—ANXA1—lung cancer	7.72e-05	0.00015	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—CYP2A6—lung cancer	7.7e-05	0.00015	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—GCLC—lung cancer	7.7e-05	0.00015	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	7.67e-05	0.000149	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—GRM8—lung cancer	7.53e-05	0.000146	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	7.49e-05	0.000145	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—POMC—lung cancer	7.37e-05	0.000143	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—IL6—lung cancer	7.34e-05	0.000142	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—APP—lung cancer	7.32e-05	0.000142	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—ENO1—lung cancer	7.3e-05	0.000142	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—SKI—lung cancer	7.29e-05	0.000141	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	7.28e-05	0.000141	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—ALB—lung cancer	7.18e-05	0.000139	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—POMC—lung cancer	6.81e-05	0.000132	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—CYP2E1—lung cancer	6.55e-05	0.000127	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—NQO1—lung cancer	6.48e-05	0.000126	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	6.34e-05	0.000123	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—MMP2—lung cancer	6.34e-05	0.000123	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—PXN—lung cancer	6.33e-05	0.000123	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—HRAS—lung cancer	6.33e-05	0.000123	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	6.28e-05	0.000122	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—AVP—lung cancer	6.27e-05	0.000122	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—GRP—lung cancer	6.2e-05	0.00012	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—OXTR—lung cancer	6.2e-05	0.00012	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—AKR1C1—lung cancer	6.2e-05	0.00012	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—STK11—lung cancer	5.84e-05	0.000113	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—GNG11—lung cancer	5.8e-05	0.000113	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—CXCL8—lung cancer	5.7e-05	0.000111	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—AVP—lung cancer	5.69e-05	0.00011	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—VEGFC—lung cancer	5.52e-05	0.000107	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.48e-05	0.000106	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—GSTP1—lung cancer	5.4e-05	0.000105	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—CXCL8—lung cancer	5.27e-05	0.000102	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—CAT—lung cancer	5.26e-05	0.000102	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.23e-05	0.000101	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—ADCY1—lung cancer	5.22e-05	0.000101	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—ABCB1—lung cancer	5.11e-05	9.93e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—SMARCA4—lung cancer	5.08e-05	9.87e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—PPP2R1B—lung cancer	5.08e-05	9.87e-05	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—TYMS—lung cancer	5.02e-05	9.75e-05	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—GSTM1—lung cancer	4.96e-05	9.64e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—HSPB1—lung cancer	4.91e-05	9.52e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—PTHLH—lung cancer	4.85e-05	9.41e-05	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—CYP1A1—lung cancer	4.71e-05	9.13e-05	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—ERCC2—lung cancer	4.67e-05	9.06e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—ANXA1—lung cancer	4.56e-05	8.85e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—FLT1—lung cancer	4.42e-05	8.57e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—PIK3CG—lung cancer	4.38e-05	8.49e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—NOTCH3—lung cancer	4.32e-05	8.39e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—APP—lung cancer	4.32e-05	8.39e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—FGF9—lung cancer	4.29e-05	8.32e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—POMC—lung cancer	4.16e-05	8.08e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—JUNB—lung cancer	4.09e-05	7.95e-05	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—APOA1—lung cancer	4.04e-05	7.84e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—PIK3CG—lung cancer	3.97e-05	7.71e-05	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.87e-05	7.5e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—PIK3CD—lung cancer	3.85e-05	7.47e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—POMC—lung cancer	3.78e-05	7.34e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—STK11—lung cancer	3.72e-05	7.22e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—IL6R—lung cancer	3.69e-05	7.16e-05	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—PIK3CG—lung cancer	3.69e-05	7.15e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—FOXO3—lung cancer	3.59e-05	6.96e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—MAP2K1—lung cancer	3.52e-05	6.82e-05	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—POMC—lung cancer	3.51e-05	6.81e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—PIK3CD—lung cancer	3.49e-05	6.78e-05	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—CREBBP—lung cancer	3.42e-05	6.63e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—AVP—lung cancer	3.36e-05	6.53e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—PIK3CB—lung cancer	3.35e-05	6.51e-05	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—PIK3CD—lung cancer	3.24e-05	6.29e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—IGF1R—lung cancer	3.24e-05	6.28e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—CXCL8—lung cancer	3.22e-05	6.25e-05	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—ALB—lung cancer	3.2e-05	6.21e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—HES1—lung cancer	3.18e-05	6.17e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—RAF1—lung cancer	3.12e-05	6.05e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—IL2—lung cancer	3.08e-05	5.98e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—PIK3CB—lung cancer	3.04e-05	5.91e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—CXCL8—lung cancer	2.93e-05	5.68e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—ERBB3—lung cancer	2.91e-05	5.64e-05	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—PIK3CB—lung cancer	2.82e-05	5.48e-05	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—PTGS2—lung cancer	2.8e-05	5.43e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—IL2—lung cancer	2.8e-05	5.43e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—TERT—lung cancer	2.79e-05	5.41e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—FGFR1—lung cancer	2.7e-05	5.25e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—HIF1A—lung cancer	2.66e-05	5.17e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—APOA1—lung cancer	2.57e-05	4.99e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—KDR—lung cancer	2.55e-05	4.95e-05	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—PTEN—lung cancer	2.44e-05	4.74e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—APC—lung cancer	2.35e-05	4.56e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—PIK3CG—lung cancer	2.35e-05	4.56e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—KIT—lung cancer	2.35e-05	4.56e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—NRAS—lung cancer	2.35e-05	4.56e-05	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—EP300—lung cancer	2.33e-05	4.52e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—EGF—lung cancer	2.32e-05	4.5e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—MAPK3—lung cancer	2.25e-05	4.36e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—POMC—lung cancer	2.23e-05	4.34e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—BRAF—lung cancer	2.21e-05	4.28e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—IL6R—lung cancer	2.18e-05	4.23e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—CREBBP—lung cancer	2.18e-05	4.22e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—EGFR—lung cancer	2.14e-05	4.15e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—MAP2K1—lung cancer	2.08e-05	4.03e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—PIK3CD—lung cancer	2.06e-05	4e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—PIK3CA—lung cancer	2.04e-05	3.97e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—KRAS—lung cancer	2.02e-05	3.92e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—PIK3CA—lung cancer	1.86e-05	3.6e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—MDM2—lung cancer	1.85e-05	3.59e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—RAF1—lung cancer	1.84e-05	3.58e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—ERBB2—lung cancer	1.82e-05	3.54e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—PIK3CB—lung cancer	1.8e-05	3.49e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—MTOR—lung cancer	1.8e-05	3.49e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—CXCL8—lung cancer	1.73e-05	3.35e-05	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—PIK3CA—lung cancer	1.72e-05	3.34e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—HRAS—lung cancer	1.72e-05	3.33e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—AKT1—lung cancer	1.67e-05	3.24e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—CASP3—lung cancer	1.65e-05	3.21e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—IL2—lung cancer	1.65e-05	3.21e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—IL6—lung cancer	1.64e-05	3.19e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—CCND1—lung cancer	1.61e-05	3.13e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—JUN—lung cancer	1.61e-05	3.12e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—MMP9—lung cancer	1.56e-05	3.03e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—CDKN1A—lung cancer	1.56e-05	3.02e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—PTEN—lung cancer	1.55e-05	3.02e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—AKT1—lung cancer	1.52e-05	2.94e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—EP300—lung cancer	1.48e-05	2.88e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—SRC—lung cancer	1.44e-05	2.8e-05	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—AKT1—lung cancer	1.41e-05	2.73e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—VEGFA—lung cancer	1.4e-05	2.72e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—STAT3—lung cancer	1.39e-05	2.7e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—NRAS—lung cancer	1.39e-05	2.69e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—MAPK3—lung cancer	1.33e-05	2.58e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—MYC—lung cancer	1.29e-05	2.51e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—EGFR—lung cancer	1.26e-05	2.45e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—KRAS—lung cancer	1.19e-05	2.32e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—PIK3CA—lung cancer	1.1e-05	2.13e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—TP53—lung cancer	1.06e-05	2.06e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—HRAS—lung cancer	1.01e-05	1.97e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—IL6—lung cancer	9.71e-06	1.88e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—AKT1—lung cancer	8.96e-06	1.74e-05	CbGpPWpGaD
